Vasodilators, particularly short-acting varieties, are useful in managing severe or refractory congestive heart failure by correcting hemodynamic effects.
May support short-acting vasodilators in refractory HF; extends historical observations but leaves open need for modern RCTs.
Vasodilators are gaining importance in management of congestive heart failure. The short-acting varieties are often helpful in severe or refractory cases, and several agents show promise for long-term therapy. An understanding of the chain of events that occurs in congestive heart failure and of the corrective hemodynamic effects of the different vasodilators is essential for proper use of these agents.
No takes yet. Share an insight, caveat, or question.
Joseph A. Franciosa (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: